companydata.dkcompanydata.dk

AVILEX PHARMA ApS: Financial statements 2018

CVR: 34896828

Source: annual report 2018, Danish Business Authority

01/01/201831/12/2018

AVILEX PHARMA ApS (CVR 34896828) has filed annual accounts for 2018. In 2018, the company reported a net result of DKK -3,860,576 compared with DKK -2,415,685 the year before. Equity in the 2018 report amounted to DKK -11,881,155. The company had 1 employee in the financial year.

Profit/Loss
DKK -3,860,576
Equity
DKK -11,881,155
Total Assets
DKK 6,748,830
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2018---3.9 mio.-11.9 mio.1
2017---2.4 mio.-8.1 mio.1
2016---5.5 mio.-5.7 mio.1
2015---7.6 mio.-279 t.3
2014---1.2 mio.-4.1 mio.0

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2018

Morten Døssing joins the board of AVILEX PHARMA ApSDec 21, 2018

As of December 21, 2018, Morten Døssing has joined the board of directors of AVILEX PHARMA ApS.

Emmanuelle Coutanceau leaves the board of AVILEX PHARMA ApSDec 21, 2018

As of December 21, 2018, Emmanuelle Coutanceau has left the board of directors of AVILEX PHARMA ApS.

AVILEX PHARMA ApS: The 2017 annual report is outMay 31, 2018

AVILEX PHARMA ApS has published its annual report for 2017. The net result was DKK -2,415,685.

Jonathan Mark Treherne joins the board of AVILEX PHARMA ApSMay 1, 2018

As of May 1, 2018, Jonathan Mark Treherne has joined the board of directors of AVILEX PHARMA ApS.

Jonathan Mark Treherne steps down as adm. dir. of AVILEX PHARMA ApSMay 1, 2018

As of May 1, 2018, Jonathan Mark Treherne has stepped down as adm. dir. of AVILEX PHARMA ApS.

About AVILEX PHARMA ApS

AVILEX PHARMA ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Kristian Strømgaard. The board consists of Raymond George Hill (chair), Camilla Petrycer Hansen, Jonathan Mark Treherne and Kristian Strømgaard. The company's owners include Novo Holdings A/S, MIKAEL SØNDERGÅRD THOMSEN ApS and KRISTIAN STRØMGAARD HOLDING ApS. The company has 3 employees (2018). In 2025, the company reported a net result of DKK -4,530,000 compared with DKK -4,428,000 the year before. Equity in the 2025 report amounted to DKK -10,797,000.

Source: annual report 2025, Danish Business Authority